Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-08 5:02 pm Purchase |
2025-07-01 | 13G | Cellectar Biosciences, Inc. CLRB |
Mitchell P. Kopin | 140,101 4.990% |
140,101 (New Position) |
Filing History |
| 2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management LLC | 83,571 5.730% |
-39,020 (-31.83%) |
Filing History |
| 2025-02-13 3:49 pm Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 131,849 8.800% |
-14,483 (-9.90%) |
Filing History |
| 2025-02-03 4:57 pm Purchase |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 249,092 9.900% |
16,744 (+7.21%) |
Filing History |
| 2025-01-27 10:07 am Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 67,407 4.900% |
-21,337 (-24.04%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management LLC | 122,591 9.990% |
14,928 (+13.87%) |
Filing History |
| 2024-11-14 4:47 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
ADAR1 Capital Management LLC | 122,824 8.510% |
122,824 (New Position) |
Filing History |
| 2024-11-14 1:26 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 146,332 9.990% |
36,993 (+33.83%) |
Filing History |
| 2024-08-14 7:15 pm Purchase |
2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 232,348 9.900% |
99,261 (+74.58%) |
Filing History |
| 2024-07-11 5:37 pm Unchanged |
2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 133,086 9.900% |
0 (Unchanged) |
Filing History |
| 2024-04-25 8:01 pm Sale |
2024-03-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 133,086 9.900% |
-89,478 (-40.20%) |
Filing History |
| 2024-02-14 8:31 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 222,564 9.900% |
150,622 (+209.36%) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management LLC | 107,663 9.900% |
107,663 (New Position) |
Filing History |
| 2024-02-14 4:29 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 43,568 9.676% |
12,315 (+39.41%) |
Filing History |
| 2024-02-14 3:23 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 109,339 9.990% |
46,504 (+74.01%) |
Filing History |
| 2024-02-07 6:58 pm Purchase |
2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 88,744 8.700% |
24,903 (+39.01%) |
Filing History |
| 2024-01-31 08:00 am Purchase |
2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB |
ADAR1 Partners LP | 60,802 6.210% |
60,802 (New Position) |
Filing History |
| 2023-12-07 5:15 pm Purchase |
2023-10-25 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 62,836 9.990% |
62,836 (New Position) |
Filing History |
| 2023-12-05 06:01 am Purchase |
2023-11-07 | 13G | Cellectar Biosciences, Inc. CLRB |
Orin Hirschman | 63,841 9.900% |
63,841 (New Position) |
Filing History |
| 2023-02-13 5:53 pm Unchanged |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 71,942 9.970% |
0 (Unchanged) |
Filing History |